Bo-liang Liu
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: May 11, 2017
The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma.
Journal: Cell death & disease
Published: August 16, 2016
E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Journal: Oncotarget
Published: May 20, 2016
Role of glycogen synthase kinase-3β inhibitor AZD1080 in ovarian cancer.
Journal: Drug design, development and therapy
Published: April 07, 2016
The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Journal: Oncotarget
Published: December 18, 2015
MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
Journal: PloS one
Published: December 08, 2015
MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
Journal: Oncotarget
Published: July 23, 2015
MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Journal: Molecular cancer
Published: July 21, 2015
MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
Journal: Journal of ovarian research
Published: June 23, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026